HLA‐B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin‐Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project-Reference-Cited by-同舟云学术

HLA‐B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin‐Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project

Published:2019-12-06 Issue:5 Volume:107 Page:1170-1178
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Hikino Keiko¹^ORCID,Ozeki Takeshi¹,Koido Masaru²,Terao Chikashi²,Kamatani Yoichiro²³,Mizukawa Yoshiko⁴,Shiohara Tetsuo⁴,Tohyama Mikiko⁵,Azukizawa Hiroaki⁶,Aihara Michiko⁷,Nihara Hiroyuki⁸,Morita Eishin⁸,Murakami Yoshinori⁹,Kubo Michiaki¹⁰,Mushiroda Taisei¹

Affiliation:

1. Laboratory for Pharmacogenomics RIKEN Center for Integrative Medical Sciences Yokohama City Kanagawa Japan

2. Laboratory for Statistical and Translational Genetics RIKEN Center for Integrative Medical Sciences Yokohama City Kanagawa Japan

3. Laboratory of Complex Trait Genomics Graduate School of Frontier Sciences The University of Tokyo Tokyo Japan

4. Department of Dermatology Kyorin University School of Medicine Tokyo Japan

5. Department of Dermatology Ehime University Graduate School of Medicine Ehime Japan

6. Department of Dermatology Osaka University Graduate School of Medicine Osaka Japan

7. Department of Environmental Immuno‐Dermatology Yokohama City University Graduate School of Medicine Yokohama Japan

8. Department of Dermatology Faculty of Medicine Shimane University Shimane Japan

9. Division of Molecular Pathology Institute of Medical Science The University of Tokyo Tokyo Japan

10. RIKEN Center for Integrative Medical Sciences Yokohama City Kanagawa Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1706

Reference45 articles.

1. Ministry of Health Labour and Welfare.Adverse drug reactions in the past 5 years (2014). Accessed January 16 2019.

2. Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine

3. Overview of the BioBank Japan Project: Study design and profile

4. Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases

5. Genome-wide association study identifies 112 new loci for body mass index in the Japanese population

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications;The Pharmacogenomics Journal;2023-08-26

2. Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru;Pharmacia;2023-08-15

3. Genetic associations of human leukocyte antigen alleles in cutaneous delayed drug hypersensitivity reactions: An updated review;Dermatologica Sinica;2023

4. Genetic abnormality of cytochrome-P2C9*3 allele predisposes to epilepsy and phenytoin-induced adverse drug reactions: genotyping findings of cytochrome-alleles in the North Indian population;Future Journal of Pharmaceutical Sciences;2022-10-27

5. Avoidance of cutaneous adverse drug reactions induced by antiepileptic drugs based on pharmacogenomics;Journal of Human Genetics;2022-05-09